Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Switch to FNB Business

Product shop

By Turnover

First Business Zero (R0 - R5 million p.a) Gold Business (R0 - R5 million p.a) Platinum Business (R5 million - R60 million p.a) Enterprise Business (R60 million - R150 million+ p.a)

Transact

Business Accounts Credit Cards Cash Solutions Merchant Services eWallet Pro Staffing Solutions ATM Solutions Ways to bank Fleet Services Guarantees

Savings and Investments

Save and Invest 3PIM (3rd Party Investment Manager)

Borrow

FNB Cash Advance Overdraft Loans Debtor Finance Leveraged Finance Private Equity Securities Based Lending Selective Invoice Discounting Asset Based Finance Alternative Energy Solutions Commercial Property Finance Fleet Services

Insure

Insurance

For my employees

Staffing Solutions Employee benefits

Forex + Trade

Foreign Exchange Imports and exports Structured Trade + Commodity Finance Business Global Account (CFC account)

Value Adds + Rewards

Connect my business the dti initiatives Enterprise and supplier development Business Hub eBucks Rewards for Business DocTrail™ CIPC Integration Channel Instant Accounting Solutions Instant Payroll Instant Cashflow Instant Invoicing SLOW 24/7 Business Desk FNB Business Fundaba nav» Marketplace Prepaid products Accounting integrations

Industry Expertise

Philanthropy Chinese Business Islamic Banking Agriculture Public Sector Education Healthcare Franchise Motor Dealership Tourism

Going Global

Global Commercial Banking

Financial Planning

Overview

Bank Better

KYC / FICA Debit order + recipient switching Electronic Alerts

Corporates + Public Sector

Corporate Public Sector

All savings + investment accounts


Cash deposits

Notice deposits Immediate access Access to a portion Fixed deposits

Share investing

Shares

Tax-free investing

Tax-free accounts

Funds/unit trusts

Ashburton specialised products

Invest abroad

Offshore products

I want to save for

Personal goals Child's education Emergencies Tax-free

Compare similar

Compare

Additional options

Show me all Help me chosse Find an advisor

Financial planning

Overview

Back

Trade Ideas

Local Trade Idea: Clicks Group (CLS) - BUY

 

By Peet Serfontein & Jalpa Bhoolia

Clicks Group is a health and beauty-focused retail and supply group. Through their market-leading retail brands, Clicks, Sorbet, Claires and The Body Shop, the group has hundreds of stores across southern Africa, while United Pharmaceutical Distributors (UPD) provides distribution capability for the group's healthcare strategy and has close to a third of market share in private pharmaceutical wholesale in South Africa.

Clicks is a defensive company and is characterised by growth, high return on equity (ROE), strong cash conversion and execution.

Technically, a price that is in a rectangle pattern, makes for an interesting investment option (see the grey shading on the main chart).

The pattern is also known as a consolidation and can support a bullish tone for a share, particularly when formed during an uptrend. It occurs when the share fluctuates between defined support and resistance levels, creating a "rectangle". The rectangular pattern often represents a period of accumulation, with steady buying activity at lower levels (support), but the price remains capped by a resistance level. This suggests that investors are gradually building positions in anticipation of a breakout.

The insert shows the Relative Price Strength (RPS) analysis for the share, comparing its performance relative to other shares on the JSE All Share Index. The black line is the price action of Clicks. The RPS ranking was inverted, allowing it to be overlaid with the price, and a ten-week average trend was calculated for both the price and ranking. An upward trend in the ranking (see the amber colour) is a bullish indicator.

The share is also in the markup phase of the Wyckoff Price Cycle thus supporting a bullish tone.

We suggest a medium capital at-risk allocation to this trade. Increase exposure for a break above R405.

Share Information

Share Code CLS
Industry Food and Drug Retailers
Market Capital (ZAR) 91.84 billion
One Year Total Return 37.97%
Return Year-to-Date 21.15%
Current Price (ZAR) 385.77
52 Week High (ZAR) 403.39
52 Week Low (ZAR) 275.50
Financial Year End August
The share has made solid progress year-to-date, with several technical indicators pointing to further upside potential. The price remains above its 200-day simple moving average (SMA).

Consensus expectations

(Bloomberg)

FY24 FY25E FY26E FY27E
Headline Earnings per Share (ZAR) 11.94 13.52 15.36 17.38
Growth (%) 13.29 13.57 13.17
Dividend Per Share (ZAR) 7.76 8.51 9.69 10.98
Growth (%) 9.64 13.83 13.37
Forward PE (times) 28.53 25.12 22.20
Forward Dividend Yield (%) 2.21 2.51 2.85
Earnings growth is expected to remain robust over the forecast term.

Buy/Sell Rationale

Technical Analysis:

    • The second chart shows occurrences of the Relative Strength Index (RSI) bullish divergence signals - indicated by a reading of 1. The signal occurs when the share price reaches a lower low, but the RSI indicator makes a higher low. This divergence can signal a potential trend reversal from bearish to bullish.
    • The steep upwards trajectory of the On-balance volume (OBV) indicator supports a bullish stance.
    • Muted downside price momentum according to the Moving Average Convergence Divergence (MACD) indicator on the weekly time interval supports the trade.
    • Our entry range is between R371 and R405. A move away from this range will signify a change in trend and would negate this trade idea.
    • Our target price is R444, representing upside of ~14.3% from current levels.
    • Our proposed time to exit is mid-November 2025, though investors can adjust for either a longer or shorter time horizon, depending on price behaviour.
    • A drop below R354 (downside of ~8.8% from current levels) would imply weakening technicals. As such, a stop-loss is recommended at this level.

Fundamental view:

    • Clicks has proven to be an excellent competitor in the retail and distribution space. The company is led by a strong management team, which has improved various operational efficiencies, lowered costs, reduced excess investment in working capital and enhanced product availability. In addition, the company boasts a high return of equity, has minimal debt and is highly cash generative.
    • The group recently reported positive year-end results, with most key metrics improving from 1H24 and coming in healthier than market estimates. The result demonstrated the resilience and defensiveness of the business model, with performance supported by margin expansion, resulting in strong cash flow generation.
    • Divisionally, margin expansion across both Retail and Distribution was another notable point. Market share gains were particularly impressive, while operational metrics have recovered to pre-systems implementation levels in UPS, with the business delivering a much improved 2H24 performance. The double-digit dividend increase was evident of a strong second half.
    • While the trading environment may be constrained over the near term, there are several cyclical tailwinds to support performance over FY25. New store openings and reiterated commitment by management towards the target of 1 200 store openings in the medium term offers a hint of optimism as well.
    • Key risks to our fundamental view include regulatory intervention within the pharmaceutical sector. Increased competition from food retailers introducing pharmacy offerings continues to pose a risk.

Share Name and Position SHP - Buy
(Continue to hold)
WHL - BUY
(Continue to hold)
TBS - BUY
(Continue to hold)
Entry 292.78 60.82 224.91
Current 314.52 64.80 238.72
Movement +7.4% +6.5% +6.1%
A price that appears to be in a phase of low volatility remains of interest. The start of upside price momentum is a positive. Remains above its 200-day simple moving average.

Our profit target is at R317.00 with a trailing stop-loss at R286. Exit the trade on 1 September 2024.
A price building a base remains of interest. Upside price momentum is encouraging. Remains above its 200-day simple moving average.

Our profit target is at R71 with a trailing stop-loss at R61.60. Exit the trade on 25 November 2024.
A price at major resistance remains of interest. Downside price momentum is a concern. Remains above its 200-day simple moving average.

Our profit target is at R260 with a trailing stop-loss at R213.90. Exit the trade on 28 April 2025.

Share Name and Position QLT - Buy
(Continue to hold)
OMU - Buy
(Continue to hold)
INL - BUY
(Continue to hold)
Entry 31.11 12.48 139.53
Current 32.62 12.65 139.17
Movement +4.9% +1.4% -0.3%
The price appears to be developing the 5th wave of the Elliott Wave Price analysis. Downward momentum is concerning. Remains above its 200-day simple moving average.

Our profit target is at R35 with a trailing stop-loss at R31.10. Exit the trade on 2 December 2024.
A price building a base remains of interest. Downside price momentum has halted. Remains above its 200-day simple moving average.

Our profit target is at R14.40 with a trailing stop-loss at R11.80. Exit the trade on 17 December 2024.
Historical seasonal strength from October to January remains of interest. Trades above its 200-day simple moving average. Fading downside momentum supports the trade.

Our take profit target remains at R155 with a trailing stop-loss level at R133. Exit the trade on 20 January 2025.

FNB Stockbroking and Portfolio Management (Pty) Ltd, a subsidiary of FirstRand Bank Limited, an authorised Financial Services Provider and authorised user of the JSE limited (Reg no: 1996/011732/07). This Publication note is issued by FNB Stockbroking and Portfolio Management (Pty) Ltd for the information of clients only and should not be produced in whole or part without prior permission. Although FNB Stockbroking and Portfolio Management (Pty) Ltd is an Authorised Financial Services Provider, any opinions and/or analysis contained in this Publication are for informational purposes only and should not be considered advice, including but not limited to financial, legal or tax advice, or a recommendation to invest in any security or to adopt any investment strategy. The information contained herein has been obtained from sources/persons which we believe to be reliable but is not guaranteed for correctness, completeness or otherwise and we do not assume liability for loss arising from errors in the information or that may be suffered from using or relying on the information contained herein irrespective of whether there has been any negligence by us, our affiliates or any other employees of us, and whether such losses be direct or consequential. As market and economic conditions are subject to rapid change, any comments, opinions, and analysis is rendered as of the date of publishing and may change without notice. Such changes may have a material impact on the outcome of any investment. Securities involve a degree of risk and are volatile instruments. Past performance is not indicative of future performances. Securities or financial instruments mentioned in the Publication note may not be suitable for all investors and FNB Stockbroking and Portfolio Management (Pty) Ltd has bares no responsibility whatsoever arising from or as a consequence hereof. The material is not intended as a complete analysis of every material fact regarding any share, instrument, sector, region, market, country, investment, or strategy. The recipient of this Publication must make their own investment decision and is advised to contact his relationship manager for a personal financial analysis prior to making any investment decisions. Copyright 2018 by FNB Stockbroking and Portfolio Management (Pty) Ltd.